Balchem (NASDAQ:BCPC) is a global specialty chemicals and ingredient manufacturer headquartered in New Hampton, New York. Since its founding in 1960, the company has developed a reputation for providing innovative solutions across a range of markets, including human and animal nutrition, food and beverage, pharmaceutical and industrial applications. Balchem’s expertise in microencapsulation, powder and liquid formulations, and specialty actives enables it to deliver performance-driven ingredients that meet stringent quality and regulatory standards.
The company’s product portfolio spans key categories such as choline chloride and other specialty nutrients for animal feed; nutrient delivery systems and taste-masking ingredients for dietary supplements and pharmaceutical applications; and specialty carriers, release agents and processing aids for industrial uses. Balchem’s microencapsulation technology allows for controlled release, flavor protection and enhanced stability, while its industrial product lines support applications ranging from metal packaging to odor management and asphalt modification.
With a presence in North America, Europe, Asia Pacific and Latin America, Balchem operates multiple manufacturing sites, research and development centers and technical support offices around the world. This global network enables the company to collaborate closely with customers on tailor-made solutions, ensure timely supply, and adapt to regional regulatory requirements. Balchem’s commitment to innovation is bolstered by ongoing investment in R&D and strategic partnerships within the specialty chemicals industry.
Under the leadership of President and Chief Executive Officer Kurt P. Smith, Balchem continues to expand its product offerings and geographic reach while maintaining a focus on sustainability, quality management and operational excellence. The company’s long track record of growth is driven by its ability to anticipate market trends, deliver high-value ingredient solutions and support customers in achieving their own performance and regulatory objectives.
